About THT
THT: Your Premier Destination for Accessing Pioneering Data and Comprehensive Updates on Heart Failure Treatments.
CRF® is proud to announce the third year of Technology and Heart Failure Therapeutics, the international conference that provides an immersive experience in the latest heart failure innovations, focusing on device- and technology-based treatments within the context of drug therapies.
What's New at THT 2024?
- Expanded presentations and discussions about unusual and complex cases.
- Deeper dive into regulatory aspects of new devices, including interactive discussions with FDA representatives.
- More multilayered discussions about controversies surrounding clinical trials of cardiogenic shock.
- Topical sessions that ignite deep discussion on long-standing electrophysiology-based treatments for heart failure — reopening the conversation on relevancy of these long-standing standard treatments in the modern era of medical therapy.
- Deep discussions on how to treat atrial fibrillation in HFrEF and HFpEF patients.
Who Should Attend THT 2024?
THT 2024 is designed for a multidisciplinary audience that includes anyone interested in heart failure management and a comprehensive overview of existing and investigational interventions. This includes:
- Heart failure specialists (fellows, nurses, physicians, and research coordinators)
- Cardiac imaging specialists
- Cardiac and vascular surgeons
- Clinical cardiologists
- Fellows in interventional cardiovascular medicine and related fields
- Industry professionals
- Interventional cardiologists
- Medical device experts
- Nurse practitioners
- Physician assistants
- Research scientists
